U2A: Fertility preservation


Ovarian tissue preservation for paediatric oncology patients

Dr Sheila Lane, Consultant Paediatric Oncologist, Oxford University Hospitals, UK

Dr Lane received her PhD from Cambridge University before qualifying as a doctor at St George’s Hospital London. In 2007 she was appointed as a Consultant Paediatric Oncologist at Oxford University Hospitals NHS Foundation Trust. She has been involved in the development and since 2014 has been the Programme Lead for the Future Fertility Programme Oxford. This programme provides children and young adults with advice and treatment options if they are at high risk of infertility. The programme has helped several thousand children in the last 10 years, has ovarian and testicular tissue stored for almost 2000 children and has successfully re-implanted tissue with the restoration of ovarian function and pregnancies for a number of young women. Dr Lane is chair of the NHSE working group which is developing service specifications for the future commissioning of national service. Dr Lane is co-PI on a number of research programmes, has co-supervised a number of PhD students and is the author of over 50 peer-reviewed papers in the area of fertility preservation for children and young adults.      


Fertility preservation in peri pubescent boys

Pippa Sangster, Consultant Urologist, Clinical Lead Male Infertility, University College London Hospital, UK

Ms Sangster is a Consultant Urologist at University College London Hospital and is the lead for male infertility. She qualified from Guy’s and St Thomas’s Medical School, London in 2001. She has further degrees in Psychology (BSc) and was awarded a gold medal in the Urology MSc before achieving FRCS (Urol). Her main area of expertise is Andrology and she is particularly interested in male factor infertility and fertility preservation. She has strong links with the Gynaecology, Endocrinology, Haematology and Oncology teams to ensure that the fertility of these patients can be preserved or helped. Men about to undergo cancer treatment or those wanting to investigate their fertility potential post chemotherapy/radiotherapy can be assessed and treated quickly.

Untitled design

Elective Egg Freezing: Socio-ethical considerations and lessons for best practice after a decade of use  

Zeynep Gurtin, Lecturer in Women’s Health, UCL Institute for Women’s Health, and Authority Member, HFEA, UK